Cerebrospinal fluid involvement in mantle cell lymphoma

Modern Pathology

Volumn 15, Issue 10, 2002, Pages 1073-1079

  Valdez, Riccardo ^a   Kroft, Steven H ^b   Ross, Charles W ^a   Schnitzer, Bertram ^a   Singleton, Timothy P ^a   Peterson, LoAnn C ^c   Finn, William G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Central nervous system; Cerebrospinal fluid; Mantle cell lymphoma; Non hodgkin's lymphoma

Indexed keywords

ADULT; AGED; ARTICLE; CELL GRANULE; CELL STRUCTURE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MULTICENTER STUDY; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADULT; AGED; CELL COUNT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROSPINAL FLUID; FEMALE; FLOW CYTOMETRY; GLUCOSE; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PROTEINS; RETROSPECTIVE STUDIES;

EID: 0036791667     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000030088.28684.5B     Document Type: Article

References (24)

1. Rimokh R, Berger F, Delsol G, et al. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993;81:3063-7.
2. Weisenburger DD, Armitage JO. Mantle cell lymphoma-an entity comes of age. Blood 1996;87:4483-94.
3. Raffeld M, Sander CA, Yano T, et al. Mantle cell lymphoma: an update. Leuk Lymphoma 1992;8:161-6.
4. Argatoff LH, Connors JM, Klasa Rj, et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1997;89: 2067-78.
5. Pittaluga S, Wlodarska I, Stul MS, et al. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology 1995;26:17-24.
6. Majlis A, Pugh WC, Rodriguez MA, et al. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol 1997;15:1664-71.
7. Bosch F, Lopez-Guillermo A, Campo E, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998;82:567-75.
8. Tworek JA, Singleton TP, Schnitzer B, et al. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma. Am J Clin Pathol 1998;110:582-9.
9. Huang JC, Finn WG, Goolsby CL, et al. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia. Am J Clin Pathol 1999;111:123-30.
10. Douglas VK, Gordon LI, Goolsby CL, et al. Lymphoid aggregates in bone marrow mimic residual lymphoma after rituximab therapy for non-Hodgkin's lymphoma. Am J Clin Pathol 1999;112:844-53.
11. Maitra A, McKenna RW, Weinberg AG, et al. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol 2001;115:868-75.
12. Kroft SH, Howard MS, Picker LJ, et al. De novo CD5-positive diffuse large B-cell lymphomas: a heterogeneous group containing an unusual form of splenic lymphoma. Am J Clin Pathol 2000;114:523-33.
13. Harris NL JE, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
14. Oinonen R, Franssila K, Elonen E. Central nervous system involvement in patients with mantle cell lymphoma. Annu Hematol 1999;78:145-9.
15. Montserrat E, Bosch F, Lopez-Guillermo A, et al. CNS involvement in mantle-cell lymphoma. J Clin Oncol 1996;14:941-4.
16. Bedotto J, Spier CM, Paquin ML, et al. Mantle zone lymphoma with central nervous system involvement. Cancer 1986;58:2125-9.
17. Meusers P, Hense J, Brittinger G. Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems. Leukemia 1997;11:S60-4.
18. Brittinger G, Bartels H, Common H, et al. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin's lymphomas: results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 1984;2:269-306.
19. Meusers P, Engelhard M, Bartels H, et al. Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis. Hematol Oncol 1989;7:365-80.
20. MacKintosh FR, Colby TV, Podolsky WJ, et al. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 1982;49:586-95.
21. Levitt LJ, Dawson DM, Rosenthal DS, et al. CNS involvement in the non-Hodgkin's lymphomas. Cancer 1980;45: 545-52.
22. Gagneten D, Hijaz YM, Jaffe ES, et al. Mantle cell lymphoma: a cytopathological and immunohistochemical study. Diagn Cytopathol 1996;14:32-7.
23. Sandlund JT, Murphy SB, Santana VM, et al. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma. J Clin Oncol 2000;18:3018-24.
24. Bollen EL, Brouwer RE, Hamers S, et al. Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients. Arch Neurol 1997;54:854-9.